The
following manuscripts are presented as online first for
peer-review, starting from March 20, 2021.
All
comments are welcome:
editor@sciencepub.net
or contact with
author(s) directly.
You can use the message in end of the article abstract to
cite it.
To get Microsoft Documents: After you open the "Full Text" for each
article, change the last 3 characters of the web address from .pdf
to .doc (or .docx)
When you submit manuscript(s),
please mention that it is submitted to the Cancer Biology.
Marsland
Press, 310 West 18th Street, New
York, NY 10011, USA. Phone: 718-404-5362; 347-321-7172
http://www.cancerbio.net
CONTENTS
No.
|
Titles /
Authors /Abstracts
|
Full Text
|
No.
|
1
|
Assessment of Tp53
Polymorphism in Hepatocellular Carcinoma with Hepatitis C Virus
Infection
Heba M. Adel Abou-zaghla1,
Aziza Ahmed Mohammed Elsebaee1, Iman Saleh
Abd-Elwahed Elhadede1, Adel Ahmed Elazab1,
Ghada Refaat Meckawy2 and Rania Mohammed Abbas1
1
Clinical and
Chemical Pathology Department, Faculty of Medicine, Ain Shams
University, Cairo, Egypt
2
Clinical Oncology
Department, Faculty of Medicine, Ain Shams University, Cairo,
Egypt
+201000775185;
Gr_mancy@yahoo.com;
Ghada_refaat@med.asu.edu.eg;
ORCID number: 000190664748
Abstract: Purpose:
The current study aims to
clarify the role of tumor protein (TP53) gene single nucleotide
polymorphism (SNP) G-C at codon 72 in the development of
hepatocellular carcinoma (HCC) among patients with chronic
hepatitis C, a step towards an efficient tool for early
detection. Methods/
patients:
We conducted this
study on 20 patients with
hepatocellular carcinoma (HCC) on top of HCV infection (group
I); 10 patients with chronic liver disease on top of HCV
infection whom age and sex were matched, serving as patient
control (group II); and 10 healthy control subjects who are age
and sex-matched with no history of hepatic complaints (group
III). TP53 G-C gene polymorphism of codon 72 was tested by
polymerase chain reaction (PCR), followed by restriction enzyme
digestion (PCR-RFLP). Results: There was a highly
statistically significant difference in TP53 G-C gene
polymorphism between the three investigated groups (p<0.01).
Conclusion: Detection of TP53 gene SNP G-C at
codon 72 is highly recommended in chronic liver disease patients
especially in known cirrhotic cases on top of HCV infection to
detect HCC patients in earlier stages.
[Heba
M. Adel Abou-zaghla, Aziza Ahmed Mohammed Elsebaee, Iman Saleh
Abd-Elwahed Elhadede, Adel Ahmed Elazab, Ghada Refaat Meckawy
and Rania Mohammed Abbas. Assessment of Tp53 Polymorphism in
Hepatocellular Carcinoma with Hepatitis C Virus Infection.
Cancer Biology
2021;11(1):1-9].
ISSN:
2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
1. doi:10.7537/marscbj110121.01.
Keywords:
HCC, TP53, HCV, early detection |
Full Text |
1
|
2
|
Mitigation of
Cisplatin-Induced Acute Kidney Injury by Punicalagin Therapy in
Mice
Nouf Khalifa
ALaqeel (1) and Meneerah Abdulrahman Al-Jafary
(2)
Department Bioligy,
College Sciences, Imam Abdlrahman Bin Fasisal University, P.O.
Box 1982, Dammam 31441, Saudi Arabia.
nalaqeel@iau.edu.sa,
maljafary@iau.edu.sa
Abstract:
The
ameliorated impact of punicalagin was studied in mice exposed to
nephrotoxicity caused by cisplatin
(5
mg/kg/, i.p.).
Punicalagin treatment (9 mg/kg/day, p.o.) was given for 5 days,
administered on the same day as cisplatin. Punicalagin greatly
ameliorated the cisplatin-induced elevations of serum creatinine,
renal nitric oxide, malondialdehyde,
tumor
necrosis factor-α, and caspase-3, and significantly increased
kidney glutathione peroxidase in mice that received cisplatin.
In addition, punicalagin markedly attenuated the
histopathological changes, and significantly decreased nuclear
factor-κB expression in the kidneys of mice that received
cisplatin. We concluded that punicalagin protected against acute
kidney injury caused by cisplatin in mice through its
antioxidant, and anti-inflammatory effects.
[Nouf
Khalifa ALaqeel and Meneerah Abdulrahman Al-Jafary.
Mitigation of Cisplatin-Induced Acute Kidney Injury by
Punicalagin Therapy in Mice.
Cancer Biology
2021;11(1):10-14].
ISSN:
2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net.
2.
doi:10.7537/marscbj110121.02.
Keywords:
Punicalagin; cisplatin; kidneys; mice |
Full Text |
2
|
3
|
Cancer
Primarily from
Wikipedia, the free encyclopedia
(https://en.wikipedia.org/wiki/Cancer)
Mark Herbert
World Development Institute
39-06 Main Street, Flushing,
Queens, New York 11354, USA,
ma708090@gmail.com
Abstract:
Cancer
is a group of diseases involving
abnormal cell
growth
with the potential to
invade or
spread to other parts of the body. These contrast with
benign tumors,
which do not spread. Possible
signs and symptoms
include a lump, abnormal bleeding, prolonged cough, unexplained
weight loss,
and a change in
bowel movements.
While these symptoms may indicate cancer, they can also have
other causes. Over 100 types of cancers affect humans.
[Mark
Herbert. Cancer.
Cancer Biology 2021;11(1):15-41]. ISSN:2150-1041(print);
ISSN:2150-105X(online).
http://www.cancerbio.net.
3. doi:10.7537/marscbj110121.03.
Keywords:
Cancer; disease;
abnormal cell
growth;
benign tumor;
symptom;
affect; human |
Full Text |
3
|
4
|
Stem Cell
Primarily from
Wikipedia, the free encyclopedia
(https://en.wikipedia.org/wiki/Cell_(biology))
Mark Herbert,
PhD
World
Development Institute
39 Main Street,
Flushing, Queens, New York 11354, USA,
ma708090@gmail.com
Abstract:
The cell is the
basic structural, functional, and biological unit of all known
organisms. Cells are the smallest units of life, and hence are
often referred to as the building blocks of life. The study of
cells is called
cell biology,
cellular biology, or cytology. Cells consist of
cytoplasm
enclosed within a
membrane,
which contains many
biomolecules
such as
proteins
and
nucleic acids.
Most plant and animal cells are only visible under a
light microscope,
with dimensions between 1 and 100
micrometres.
Electron microscopy
gives a much higher resolution showing greatly detailed cell
structure. Organisms can be classified as
unicellular
or
multicellular.
Most
unicellular
organisms
are classed as
microorganisms.
The number of cells in plants and animals varies from species to
species; it has been estimated that humans contain somewhere
around 40 trillion (4×1013) cells. The human brain
accounts for around 80 billion of these cells. Cells were
discovered by
Robert Hooke
in 1665, who named them for their resemblance to cells inhabited
by
Christian monks
in a monastery.
Cell theory,
first developed in 1839 by
Matthias Jakob
Schleiden
and
Theodor Schwann,
states that all organisms are composed of one or more cells,
that cells are the fundamental unit of structure and function in
all living organisms, and that all cells come from pre-existing
cells.[9]
Cells emerged on Earth at least 3.5 billion years ago.
[Mark
Herbert.
Stem Cell. Cancer
Biology
2021;11(1):42-53].ISSN:2150-1041(print); ISSN:2150-105X(online).
http://www.cancerbio.net.
4. doi:10.7537/marscbj110121.04.
Keywords:
cell; biological unit; organism; biology; cytology;
cytoplasm;
membrane;
biomolecule;
protein;
nucleic acid;
plant; animal;
unicellular;
multicellular;
microorganisms |
Full Text |
4
|
5
|
RNA vaccine
Primarily from
Wikipedia, the free encyclopedia
(https://en.wikipedia.org/wiki/RNA_vaccine)
Mark Herbert,
PhD
World
Development Institute
39 Main Street,
Flushing, Queens, New York 11354, USA,
ma708090@gmail.com
Abstract:
An RNA vaccine or
mRNA (messenger RNA) vaccine is a type of
vaccine
that uses a copy of a natural chemical called
messenger RNA
(mRNA) to produce an immune response. The vaccine
transfects
molecules of
synthetic RNA into
immunity cells.
Once inside the immune cells, the vaccine's RNA functions as
mRNA, causing the cells to build the foreign
protein
that would normally be produced by a
pathogen
or by a cancer cell. These protein molecules stimulate an
adaptive immune
response
which teaches the body how to identify and destroy the
corresponding pathogen or cancer cells. The
delivery
of mRNA is achieved by a co-formulation of the molecule into
lipid nanoparticles
which protect the RNA strands and helps their absorption into
the cells.
[Mark
Herbert. RNA vaccine. Cancer
Biology 2021;11(1):54-63]. ISSN:2150-1041(print); ISSN:2150-105X(online).
http://www.cancerbio.net.
5. doi:10.7537/marscbj110121.05.
Keywords:
RNA vaccine; immune response;
synthetic RNA;
immunity cells;
pathogen;
cancer cell |
Full Text |
5
|
The manuscripts in this
issue were presented as online first for peer-review starting
from
March 20, 2021.
All comments are
welcome:
editor@sciencepub.net
For
back issues of the Researcher,
click here.
Email:
editor@sciencepub.net
|